These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9834920)

  • 1. [Adverse reactions to iopromide].
    Cuñat A; Chuliá R
    Med Clin (Barc); 1998 Oct; 111(11):437. PubMed ID: 9834920
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopromide-induced encephalopathy following coronary angioplasty.
    Kocabay G; Karabay CY
    Perfusion; 2011 Jan; 26(1):67-70. PubMed ID: 20921088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-induced monoplegia following coronary angioplasty with iopromide.
    Aykan A; Zehir R; Karabay CY; Kocabay G
    Kardiol Pol; 2012; 70(5):499-500. PubMed ID: 22623245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of electrocardiogram showing ST depression after nonionic contrast media (iopromide) administration].
    Tsuruta S; Matayoshi H; Nagamizo D; Morimoto Y; Sakabe T
    Masui; 2008 Feb; 57(2):219-22. PubMed ID: 18277577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatotoxicity caused by iopromide].
    Bolado Concejo F; Capdevila Bastons F; Zozaya Urmeneta JM; González de la Higuera B; García Sanchotena JL
    Rev Esp Enferm Dig; 2008 Jun; 100(6):377-8. PubMed ID: 18752373
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of nonionic contrast media. Trends and experience with iopromide.
    Schild HH
    Invest Radiol; 1994 May; 29 Suppl 1():S112-7. PubMed ID: 8071038
    [No Abstract]   [Full Text] [Related]  

  • 9. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions.
    Böhm I; Speck U; Schild H
    Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced encephalopathy following coronary angioplasty with iopromide.
    Jiang X; Li J; Chen X
    Neurosciences (Riyadh); 2012 Oct; 17(4):378-9. PubMed ID: 23022906
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-center clinical study on the effect of chronic renal impairment on safety of iopromide 300 mg iodine/ml.
    Harz C; Fallenberg EM; Schäfer R; Magnusson A; Clauss W; Heindel W; Tombach B
    Acad Radiol; 2002 Aug; 9 Suppl 2():S535-9. PubMed ID: 12188331
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of radiographic contrast media on myocardial tissue oxygen tension: NaCl-controlled, randomised, comparative study of iohexol versus iopromide in an animal model.
    Jung F; Matschke K; Mrowietz C; Tugtekin SM; Geissler T; Keller S; Spitzer SG
    Clin Hemorheol Microcirc; 2003; 29(1):53-61. PubMed ID: 14561904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonionic contrast media induced sialadenitis following coronary angiography.
    Erdoğan D; Güllü H; Calişkan M; Ulus T; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):270-1. PubMed ID: 16943115
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver injury after contrast-enhanced, computed tomography with iopromide.
    Re G; Lanzarini C; Melandri R
    J Toxicol Clin Toxicol; 1998; 36(3):261-2. PubMed ID: 9656987
    [No Abstract]   [Full Text] [Related]  

  • 15. New clinical trial experience with iopromide.
    Goldstein HA; Jacob G; Wiggins JR
    Invest Radiol; 1994 Jun; 29 Suppl 2():S208-10. PubMed ID: 7928233
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of the non-ionic angiography contrast medium iopromide on contact phase activation and the blood coagulation system].
    Engel Z; Heller W; Hoffmeister HM; Hoffmeister HE
    Vasa Suppl; 1991; 32():356-9. PubMed ID: 1771533
    [No Abstract]   [Full Text] [Related]  

  • 17. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Pinès E; Zamia P; Idée JM
    J Invasive Cardiol; 2005 Feb; 17(2):123-4. PubMed ID: 15770762
    [No Abstract]   [Full Text] [Related]  

  • 18. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Gayet JL; Lefevre T
    J Invasive Cardiol; 2005 Feb; 17(2):124. PubMed ID: 15770763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ionic and non-ionic roentgen-contrast media upon ex vivo hemostasis in rabbits].
    Klimanova EV; Petrukhina GN; Makarov VA; Sergeev PV; Bolotova EN; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2006; 69(1):60-4. PubMed ID: 16579063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast medium and patients at risk: asthma.
    Boehm I
    Acta Radiol; 2009 Apr; 50(3):348. PubMed ID: 19234895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.